Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Derer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
MMW Fortschritte Der Medizin|August 25, 2012
[Antihypertensive therapy: individual concepts are required]Wolfgang Derer
MMW Fortschritte Der Medizin|May 27, 2011
[Interactions with antihypertensive drugs]Wolfgang Derer
Journal of Molecular Medicine (Berlin, Germany)|April 30, 2008
Aliskiren--mode of action and preclinical dataDominik N Müller, Wolfgang Derer, Ralf Dechend
MMW Fortschritte Der Medizin|May 25, 2012
[New antihypertensive drugs]Wolfgang Derer, Dominik N Müller, Ralf Dechend
MMW Fortschritte Der Medizin|December 8, 2011
[The role of triple-drug, fixed-dose combinations for the treatment of hypertension]Wolfgang Derer, Dominik N Müller, Ralf Dechend
Journal of Clinical Hypertension (Greenwich, Conn.)|August 7, 2012
Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A RegistryRalf Dechend, Edelgard Kaiser, Wolfgang Derer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
Lactate in a laubenpieperWolfgang Derer, Saban Elitok, Theresa Claus, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Long-term follow-up of patients with atherosclerotic renal artery diseaseErdal Safak, Caroline Wilke, Wolfgang Derer, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Vitronectin concentrations predict risk in patients undergoing coronary stentingWolfgang Derer, Elliot S Barnathan, Erdal Safak, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 19, 2007
Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genesRalf Dechend, Erdenechimeg Shagdarsuren, Petra Gratze, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
MMW Fortschritte Der Medizin|August 25, 2012
[Antihypertensive therapy: individual concepts are required]Wolfgang Derer
MMW Fortschritte Der Medizin|May 27, 2011
[Interactions with antihypertensive drugs]Wolfgang Derer
Journal of Molecular Medicine (Berlin, Germany)|April 30, 2008
Aliskiren--mode of action and preclinical dataDominik N Müller, Wolfgang Derer, Ralf Dechend
MMW Fortschritte Der Medizin|May 25, 2012
[New antihypertensive drugs]Wolfgang Derer, Dominik N Müller, Ralf Dechend
MMW Fortschritte Der Medizin|December 8, 2011
[The role of triple-drug, fixed-dose combinations for the treatment of hypertension]Wolfgang Derer, Dominik N Müller, Ralf Dechend
Journal of Clinical Hypertension (Greenwich, Conn.)|August 7, 2012
Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A RegistryRalf Dechend, Edelgard Kaiser, Wolfgang Derer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
Lactate in a laubenpieperWolfgang Derer, Saban Elitok, Theresa Claus, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Long-term follow-up of patients with atherosclerotic renal artery diseaseErdal Safak, Caroline Wilke, Wolfgang Derer, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Vitronectin concentrations predict risk in patients undergoing coronary stentingWolfgang Derer, Elliot S Barnathan, Erdal Safak, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 19, 2007
Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genesRalf Dechend, Erdenechimeg Shagdarsuren, Petra Gratze, et al.
Pageof 2